Background: Coronavirus disease 2019 (COVID-19) is threatening human physical and mental health. The features of mild and severe cases of COVID-19 may be different, and the impact of psychological intervention is not clear. It is necessary to analyze clinical and psychological characteristics of COVID-19 patients simultaneously. Objective: To evaluate the clinical and psychological differences between mild and severe COVID-19 patients and determine the efficacy of psychological intervention on the patients. Methods: Clinical and psychological data of the patients with COVID-19 were collected. The patients were grouped into mild and severe groups according to their clinical symptoms, and subdivided into psychological intervention group and non-psychological intervention group according to whether they received psychological intervention. The efficiency of psychological interventions in patients with emotional disorder was further explored. Results: 162 participants were included in this study (severe group: 41 patients, mild group: 121 patients), 72 of them received psychological assessment. The demographic, clinical and laboratory characteristics of mild and severe cases were quite different. Most patients in both groups showed mild to moderate anxiety and depression at admission. After psychological intervention for about three weeks, psychological scale scores (HAMA and HAMD score) of patients in the psychological intervention group (n=54) were significantly lower than those in the non-psychological intervention group (n=18) (P<0.05). Conclusions: Early psychological intervention can significantly improve the emotional state of COVID-19 patients. Comprehensive treatments comprising combined clinical and psychological interventions may be effective in the treatment of COVID-19 patients. The physical and mental health of COVID-19 patients requires long-term follow-up.
| Published in | Biomedical Sciences (Volume 7, Issue 1) |
| DOI | 10.11648/j.bs.20210701.16 |
| Page(s) | 29-35 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
COVID-19, Clinical, Depression, Anxiety, Psychological Intervention
| [1] | Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza- Gorrochategui M, et al. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020, 36 (4): e00054020. |
| [2] | Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China. JAMA. 2020, 323 (14): 1406-7. |
| [3] | Gandhi RT, Lynch JB, Del Rio C. Mild or Moderate Covid-19. N Engl J Med. 2020, 383 (18): 1757-1766. |
| [4] | Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395 (10223): 497-506. |
| [5] | Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry. 2020, 7 (4): 300-302. |
| [6] | World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance, [Accessed 31 January 2020]. https://www.who.int/publications/i/item/clinical-management-of-covid-19. |
| [7] | The General Office of the National Health and Health Commission of the People's Republic of China, the Office of the State Administration of Traditional Chinese Medicine. The Novel Coronavirus Pneumonia Diagnosis and Treatment Program (7th Edition) of China. Chin Med. 2020, 15 (6): 801-5. |
| [8] | Zimmerman M, Thompson JS, Diehl JM, et al. Is the DSM-5 Anxious Distress Specifier Interview a valid measure of anxiety in patients with generalized anxiety disorder: A comparison to the Hamilton Anxiety Scale. Psychiatry Res. 2020, 286: 112859. |
| [9] | Moazen-Zadeh E, Bayanati S, Ziafat K, et al. Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled clinical trial. J Psychopharmacol. 2020, 34 (5): 506-13. |
| [10] | Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020, 81 (2): 16-25. |
| [11] | Kunutsor SK, Laukkanen JA. Cardiovascular complications in COVID-19: A systematic review and meta-analysis. J Infect. 2020, 81 (2): e139-141. |
| [12] | Porzionato A, Emmi A, Barbon S, et al. Sympathetic activation: a potential link between comorbidities and COVID-19. FEBS J. 2020, 287 (17): 3681-3688. |
| [13] | Lemke G, Silverman GJ. Blood clots and TAM receptor signaling in COVID-19 pathogenesis. Nat Rev Immunol. 2020, 20 (7): 395-396. |
| [14] | Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol, 2020, 73 (3): 566-574. |
| [15] | Taghiloo S, Aliyali M, Abedi S, et al. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics. J Med Virol. 2020 Sep 10. |
| [16] | Piano S, Dalbeni A, Vettore E, et al. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19. Liver Int. 2020, 40 (10): 2394-2406. |
| [17] | Sher L. COVID-19, anxiety, sleep disturbances, and suicide. Sleep Med. 2020, 70: 124. |
| [18] | Solomou I, Constantinidou F. Prevalence and Predictors of Anxiety and Depression Symptoms during the COVID-19 Pandemic and Compliance with Precautionary Measures: Age and Sex Matter. Int J Environ Res Public Health. 2020, 17 (14): 4924. |
| [19] | Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020, (7): 611-27. |
| [20] | Kawohl W, Nordt C. COVID-19, unemployment, and suicide. Lancet Psychiatry. 2020, 7 (5): 389-90. |
| [21] | Gonzalez-Sanguino C, Ausin B, AngelCastellanos M, et al. Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun. 2020, 87: 172–176. |
APA Style
Song Wang, Meilan Su, Minghong Zhang, Yanshu Guo, Shuhong Han, et al. (2021). Analysis of Clinical and Psychological Characteristics on Mild and Severe COVID-19 Patients. Biomedical Sciences, 7(1), 29-35. https://doi.org/10.11648/j.bs.20210701.16
ACS Style
Song Wang; Meilan Su; Minghong Zhang; Yanshu Guo; Shuhong Han, et al. Analysis of Clinical and Psychological Characteristics on Mild and Severe COVID-19 Patients. Biomed. Sci. 2021, 7(1), 29-35. doi: 10.11648/j.bs.20210701.16
AMA Style
Song Wang, Meilan Su, Minghong Zhang, Yanshu Guo, Shuhong Han, et al. Analysis of Clinical and Psychological Characteristics on Mild and Severe COVID-19 Patients. Biomed Sci. 2021;7(1):29-35. doi: 10.11648/j.bs.20210701.16
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.bs.20210701.16,
author = {Song Wang and Meilan Su and Minghong Zhang and Yanshu Guo and Shuhong Han and Hongmei Wu and Yunfei Duan and Jing Guan and Zhonghui Zou and Zubin Yin},
title = {Analysis of Clinical and Psychological Characteristics on Mild and Severe COVID-19 Patients},
journal = {Biomedical Sciences},
volume = {7},
number = {1},
pages = {29-35},
doi = {10.11648/j.bs.20210701.16},
url = {https://doi.org/10.11648/j.bs.20210701.16},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bs.20210701.16},
abstract = {Background: Coronavirus disease 2019 (COVID-19) is threatening human physical and mental health. The features of mild and severe cases of COVID-19 may be different, and the impact of psychological intervention is not clear. It is necessary to analyze clinical and psychological characteristics of COVID-19 patients simultaneously. Objective: To evaluate the clinical and psychological differences between mild and severe COVID-19 patients and determine the efficacy of psychological intervention on the patients. Methods: Clinical and psychological data of the patients with COVID-19 were collected. The patients were grouped into mild and severe groups according to their clinical symptoms, and subdivided into psychological intervention group and non-psychological intervention group according to whether they received psychological intervention. The efficiency of psychological interventions in patients with emotional disorder was further explored. Results: 162 participants were included in this study (severe group: 41 patients, mild group: 121 patients), 72 of them received psychological assessment. The demographic, clinical and laboratory characteristics of mild and severe cases were quite different. Most patients in both groups showed mild to moderate anxiety and depression at admission. After psychological intervention for about three weeks, psychological scale scores (HAMA and HAMD score) of patients in the psychological intervention group (n=54) were significantly lower than those in the non-psychological intervention group (n=18) (PConclusions: Early psychological intervention can significantly improve the emotional state of COVID-19 patients. Comprehensive treatments comprising combined clinical and psychological interventions may be effective in the treatment of COVID-19 patients. The physical and mental health of COVID-19 patients requires long-term follow-up.},
year = {2021}
}
TY - JOUR T1 - Analysis of Clinical and Psychological Characteristics on Mild and Severe COVID-19 Patients AU - Song Wang AU - Meilan Su AU - Minghong Zhang AU - Yanshu Guo AU - Shuhong Han AU - Hongmei Wu AU - Yunfei Duan AU - Jing Guan AU - Zhonghui Zou AU - Zubin Yin Y1 - 2021/03/12 PY - 2021 N1 - https://doi.org/10.11648/j.bs.20210701.16 DO - 10.11648/j.bs.20210701.16 T2 - Biomedical Sciences JF - Biomedical Sciences JO - Biomedical Sciences SP - 29 EP - 35 PB - Science Publishing Group SN - 2575-3932 UR - https://doi.org/10.11648/j.bs.20210701.16 AB - Background: Coronavirus disease 2019 (COVID-19) is threatening human physical and mental health. The features of mild and severe cases of COVID-19 may be different, and the impact of psychological intervention is not clear. It is necessary to analyze clinical and psychological characteristics of COVID-19 patients simultaneously. Objective: To evaluate the clinical and psychological differences between mild and severe COVID-19 patients and determine the efficacy of psychological intervention on the patients. Methods: Clinical and psychological data of the patients with COVID-19 were collected. The patients were grouped into mild and severe groups according to their clinical symptoms, and subdivided into psychological intervention group and non-psychological intervention group according to whether they received psychological intervention. The efficiency of psychological interventions in patients with emotional disorder was further explored. Results: 162 participants were included in this study (severe group: 41 patients, mild group: 121 patients), 72 of them received psychological assessment. The demographic, clinical and laboratory characteristics of mild and severe cases were quite different. Most patients in both groups showed mild to moderate anxiety and depression at admission. After psychological intervention for about three weeks, psychological scale scores (HAMA and HAMD score) of patients in the psychological intervention group (n=54) were significantly lower than those in the non-psychological intervention group (n=18) (PConclusions: Early psychological intervention can significantly improve the emotional state of COVID-19 patients. Comprehensive treatments comprising combined clinical and psychological interventions may be effective in the treatment of COVID-19 patients. The physical and mental health of COVID-19 patients requires long-term follow-up. VL - 7 IS - 1 ER -
Information
Email: